Midazolam Description Midazolam is a water-soluble benzodiazepine derivative characterized by rapid onset and short duration of action. It has anxiolytic, sedative, hypnotic and anticonvulsant characteristics as well as possible muscle relaxant characteristic. Presentation Dormax IV/IM Injection : Each 3 ml ampoule contains Midazolam Hydrochloride equivalent to Midazolam BP 15 mg. Indications Conscious/Procedural sedation prior to […]
Carboxymethylcellulose Sodium Description Drylief is indicated for use as a lubricant in dry eye (keratoconjunctivitis sicca) including temporary relief of burning, irritation, and/or discomfort due to dryness of the eye. Presentation Drylief Sterile Eye Drops: Each ml contains Carboxymethylcellulose Sodium USP 10 mg.Preservative: Sodium Perborate BP 0.01%. Indications Drylief is indicated for use as a […]
Amlodipine Besilate + Olmesartan Medoxomil Description This product is a combination of two antihypertensive drugs: a dihydropyridine calcium antagonist (calcium ion antagonist or slow-channel blocker), amlodipine besilate, and an angiotensin II receptor blocker, olmesartan medoxomil. The amlodipine component inhibits the transmembrane influx of calcium ions into vascular smooth muscle and cardiac muscle, and the olmesartan […]
Esomeprazole Description Esomeprazole is the S-isomer of Omeprazole, a proton pump inhibitor. Esomeprazole suppresses gastric acid secretion by specific inhibition of the H+/K+ATPase in the gastric parietal cell. Presentation Emep®20 Capsule : Each capsule contains Esomeprazole Magnesium Trihydrate USP equivalent to Esomeprazole 20 mg as enteric coated pellets. Emep®40 Capsule : Each capsule contains Esomeprazole […]
Empagliflozin Description Sodium-glucose co-transporter 2 (SGLT2) is the predominant transporter responsible for reabsorption of glucose from the glomerular filtrate back into the circulation. Empagliflozin is an inhibitor of SGLT2. By inhibiting SGLT2, Empagliflozin reduces renal reabsorption of filtered glucose and lowers the renal threshold for glucose, and thereby increases urinary glucose excretion. Presentation Empaglif 10 […]
Empagliflozin INN & Metformin Hydrochloride BP Empaglif-M combines 2 anti-hyperglycemic agents with complementary mechanisms of action to improve glycemic control in patients with type 2 diabetes: Empagliflozin, a sodium-glucose co-transporter 2 (SGLT2) inhibitor, and metformin, a member of the biguanide class. Description Empagliflozin: Sodium-glucose co-transporter 2 (SGLT2) is the predominant transporter responsible for reabsorption of […]
Description Epinastine is a topically active antihistamine that antagonizes both histamine H1 and H2 receptors. Moreover, it has mast cell stabilizing activity and prevents the release of inflammatory mediators from blood vessel. Epinastine does not penetrate the blood-brain barrier and therefore is not expected to induce side effects of the central nervous system. Presentation Epinast […]
Erdon contains diclofenac sodium, a non-steroidal substance with anti-inflammatory and analgesic effects. Inhibition of prostaglandin synthesis, which has been demonstrated in experiments, is considered to be fundamental to the mechanism of action of diclofenac. Prostaglandin plays a major role in the pathogenesis of inflammation and pain. Erdon has an anti-inflammatory effect when given after surgery […]
Ertinib (Erlotinib) tablet contains 100 mg or 150 mg of Erlotinib which is a tyrosine kinase inhibitor. Description Epidermal growth factor receptor (EGFR) is expressed on the cell surface of both normal and cancer cells. In some tumor cells signaling through this receptor plays a role in tumor cell survival and proliferation. Erlotinib reversibly inhibits the kinase […]
Description Etoricoxib is a non-steroidal anti-inflammatory drug (NSAID) that exhibits anti-inflammatory, analgesic, and antipyretic activities. Etoricoxib is a potent, orally active & highly selective cyclooxygenase-2 (COX-2) inhibitor. COX-2 is primarily responsible for the synthesis of prostanoid mediators of pain, inflammation and fever. Etoricoxib decreases these clinical signs and symptoms effectively with decreased GI toxicity. Moreover […]